The Board of Directors of Piramal Finance Limited, at its meeting held on March 27, 2026, approved a significant scheme of amalgamation. This strategic move involves merging three wholly-owned subsidiaries—Piramal Corporate Tower Private Limited, Piramal Agastya Offices Private Limited, and DHFL Investments Limited—directly into Piramal Finance Limited. The merger, conducted under Sections 230 to 232 of the Companies Act, 2013, aims to streamline the corporate structure and consolidate resources within the group.

The amalgamation is designed to integrate the business operations of these subsidiaries with the parent company to enhance operational efficiencies and reduce administrative overheads. Following the recommendation of the Audit Committee, the Board determined that the merger would be in the best interest of the company’s shareholders and creditors. This consolidation follows the company’s transition in April 2025 from a Housing Finance Company (HFC) to an NBFC-Investment and Credit Company (NBFC-ICC).

Piramal Finance Limited, a subsidiary of Piramal Enterprises Limited, is a leading player in India’s financial services sector, focusing on retail and wholesale lending. In early 2025, the company received its certificate of registration to operate as an NBFC-ICC, allowing it to diversify its product suite into personal loans, used car loans, and small business loans alongside its core mortgage business. Recent updates from 2025 and early 2026 highlight a significant credit rating upgrade to ‘AA+; Stable’ by CARE and CRISIL, reflecting improved confidence in its credit profile. Additionally, the company successfully raised USD 400 million through External Commercial Borrowings (ECB) in February 2026 to further fuel its growth.

For the quarter ended December 31, 2025 (Q3 FY2026), Piramal Finance reported a total income of ₹2,975.09 Crores, representing a 2.6% growth over the previous quarter. The consolidated Profit After Tax (PAT) for the same period stood at ₹401.01 Crores, a substantial increase compared to the previous year. This growth was driven by a 23% year-on-year increase in Assets Under Management (AUM), which reached ₹96,690 Crores by the end of 2025. Notable institutional investors and partners associated with the Piramal Group include the Carlyle Group, which holds a significant stake in the pharma business, and global entities like the Gates Foundation and Goldman Sachs that have partnered with or invested in group initiatives.